Fasiplon binds strongly to benzodiazepine sites on the [[GABAA receptor|GABA<sub>A</sub>]] [[Receptor (biochemistry)|receptor]] and has similar [[anxiolytic]] effects in animals, but with less [[sedative]] or [[muscle relaxant]] action.<ref name="pmid1648620">{{cite journal |vauthors=Tully WR, Gardner CR, Gillespie RJ, Westwood R |title=2-(oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors |journal=Journal of Medicinal Chemistry |volume=34 |issue=7 |pages=2060â€“7 |date=July 1991 |pmid=1648620 |doi= 10.1021/jm00111a021|url=}}</ref> It was developed by a team at [[Roussel Uclaf]] in the 1990s<ref>US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making</ref>
